Valuation: Takeda Pharmaceutical Company Limited

Capitalization 8,825B 55.44B 47.08B 43.47B 40.98B 76.03B 5,159B 77.35B 510B 200B 2,482B 208B 204B P/E ratio 2026 *
50.5x
P/E ratio 2027 * 35.4x
Enterprise value 12,764B 80.19B 68.1B 62.88B 59.28B 110B 7,462B 112B 737B 289B 3,590B 301B 295B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.73x
Free-Float
99.61%
Yield 2026 *
3.54%
Yield 2027 * 3.6%

Last Transcript: Takeda Pharmaceutical Company Limited

1 day-1.06%
1 week-4.04%
Current month-1.38%
1 month-2.63%
3 months+10.11%
6 months+32.65%
Current year+15.53%
1 week 5,582
Extreme 5582
5,757
1 month 5,515
Extreme 5515
6,033
Current year 4,863
Extreme 4863
6,033
1 year 4,000
Extreme 4000
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2015
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 59 01/06/2014
Director/Board Member 60 01/06/2015
Director/Board Member 74 01/06/2016
Change 5d. change 1-year change 3-years change Capi.($)
-1.06%-4.04%+33.32%+25.08% 56.04B
+2.38%-1.15%+10.56%+149.40% 809B
+0.26%-1.36%+49.38%+41.98% 565B
+0.86%+1.76%+22.32%+31.28% 370B
+0.78%-0.35%+24.06%+13.94% 320B
+1.50%-1.06%+48.83%+27.44% 312B
+1.49%-3.36%+50.44%+2.03% 285B
+0.71%-3.06%+30.24%+33.98% 286B
+1.35%+0.81%+27.62%+42.65% 189B
+1.24%+8.21%-33.23%-55.23% 180B
Average +0.96%-1.78%+26.35%+31.25% 337.04B
Weighted average by Cap. +1.24%-2.44%+27.22%+53.09%

Financials

2026 *2027 *
Net sales 4,530B 28.46B 24.17B 22.32B 21.04B 39.03B 2,648B 39.71B 262B 103B 1,274B 107B 105B 4,585B 28.8B 24.46B 22.58B 21.29B 39.5B 2,680B 40.18B 265B 104B 1,289B 108B 106B
Net income 173B 1.09B 925M 855M 806M 1.49B 101B 1.52B 10.02B 3.93B 48.79B 4.09B 4B 249B 1.56B 1.33B 1.23B 1.16B 2.14B 146B 2.18B 14.37B 5.63B 70B 5.87B 5.74B
Net Debt 3,939B 24.75B 21.02B 19.41B 18.29B 33.94B 2,303B 34.53B 227B 89.14B 1,108B 92.85B 90.91B 3,694B 23.21B 19.71B 18.2B 17.15B 31.82B 2,159B 32.38B 213B 83.59B 1,039B 87.06B 85.24B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Employees
47,455
Date Price Change Volume
17/04/26 5,586.00 ¥ -1.06% 5,111,600
16/04/26 5,646.00 ¥ -0.14% 3,812,900
15/04/26 5,654.00 ¥ +0.89% 3,779,900
14/04/26 5,604.00 ¥ -0.57% 3,179,400
13/04/26 5,636.00 ¥ -1.67% 4,180,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
5,646.00JPY
Average target price
6,036.87JPY
Spread / Average Target
+6.92%

Quarterly revenue - Rate of surprise